Zynex, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZYXI research report →
About the company
Zynex, Inc. , operating through its subsidiaries, specializes in the development, production, and sale of medical devices. These devices primarily utilize electrical stimulation to alleviate both chronic and acute pain, and to stimulate and exercise muscles for rehabilitation.
- CEO
- Steven Lewis Dyson
- IPO
- 2004
- Employees
- 1,000
- HQ
- Englewood, CO, US
Price Chart
- Market Cap
- $3.80M
- P/E
- -0.02
- P/S
- 0.02
- P/B
- -0.04
- EV/EBITDA
- -0.93
- Div Yield
- 0.00%
- Gross Margin
- 71.64%
- Op Margin
- -62.76%
- Net Margin
- -68.35%
- ROE
- -1807.05%
- ROIC
- -224.51%
- Revenue
- $192.35M · 4.36%
- Net Income
- $2.99M · -69.24%
- EPS
- $0.09 · -66.67%
- Op Income
- $5.99M
- FCF YoY
- -26.63%
- 52W High
- $8.45
- 52W Low
- $0.03
- 50D MA
- $0.93
- 200D MA
- $1.78
- Beta
- 1.00
- Avg Volume
- 7.25M
Get TickerSpark's AI analysis on ZYXI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 26, 26 | MICHAELS BARRY D | sell | 80,001 |
| Mar 26, 26 | Disbrow Joshua R. | sell | 12,499 |
| Mar 26, 26 | Disbrow Joshua R. | sell | 89,501 |
| Mar 26, 26 | Cress Michael D | sell | 12,499 |
| Mar 26, 26 | Cress Michael D | sell | 82,501 |
| Jun 5, 21 | MOORHEAD DANIEL J | other | 5,000 |
| Jun 7, 21 | MOORHEAD DANIEL J | other | 2,314 |
Our ZYXI coverage
Recent articles, reports, and earnings notes.
No research on ZYXI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ZYXI report →Similar companies
Peers in the same neighborhood.